Nordea Investment Management
RPRX icon

Nordea Investment Management’s Royalty Pharma RPRX Stock Holding History

Nordea Investment Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146M Buy
2,576,772
+1,788,750
+227% +$93.1M 0.12% 172
2026
Q1 		$37.3M Sell
788,022
-24,641
-3% -$1.08M 0.03% 304
2025
Q4 		$31.6M Buy
812,663
+36,664
+5% +$1.4M 0.03% 316
2025
Q3 		$27.1M Buy
775,999
+120,004
+18% +$4.34M 0.02% 319
2025
Q2 		$23.7M Buy
655,995
+562,799
+604% +$18.6M 0.02% 317
2025
Q1 		$2.88M Buy
93,196
+65,403
+235% +$2.07M ﹤0.01% 635
2024
Q4 		$708K Sell
27,793
-551,229
-95% -$14.6M ﹤0.01% 849
2024
Q3 		$16.3M Buy
579,022
+554,381
+2,250% +$15.4M 0.02% 340
2024
Q2 		$657K Hold
24,641
– – ﹤0.01% 857
2024
Q1 		$755K Buy
24,641
+1,970
+9% +$58.1K ﹤0.01% 860
2023
Q4 		$634K Hold
22,671
– – ﹤0.01% 887
2023
Q3 		$607K Hold
22,671
– – ﹤0.01% 892
2023
Q2 		$689K Buy
22,671
+669
+3% +$22.7K ﹤0.01% 869
2023
Q1 		$797K Buy
22,002
+912
+4% +$33.8K ﹤0.01% 835
2022
Q4 		$832K Sell
21,090
-860
-4% -$35.9K ﹤0.01% 806
2022
Q3 		$889K Buy
21,950
+1,141
+5% +$48.7K ﹤0.01% 796
2022
Q2 		$865K Sell
20,809
-305,945
-94% -$12.5M ﹤0.01% 817
2022
Q1 		$12.7M Buy
326,754
+9,211
+3% +$362K 0.02% 361
2021
Q4 		$12.8M Buy
317,543
+175,648
+124% +$6.82M 0.02% 368
2021
Q3 		$5.25M Buy
141,895
+135,897
+2,266% +$5.28M 0.01% 596
2021
Q2 		$246K Hold
5,998
– – ﹤0.01% 976
2021
Q1 		$266K Hold
5,998
– – ﹤0.01% 957
2020
Q4 		$300K Buy
+5,998
New +$254K ﹤0.01% 908

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nordea Investment Management's RPRX Position: Q2 2026 in Review

Nordea Investment Management increased its Royalty Pharma (RPRX) stake by 227% in Q2 2026, buying an estimated $93.1M and bringing the position to 2,576,772 shares worth $146M. The position accounts for 0.12% of the portfolio, ranked #172.

Nordea Investment Management first reported a position in RPRX in Q4 2020 and has held it in 23 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Nordea Investment Management held 2,576,772 shares of Royalty Pharma worth $146M as of Q2 2026.
  • Nordea Investment Management bought 1,788,750 Royalty Pharma shares in Q2 2026, an estimated $93.1M.
  • Royalty Pharma made up 0.12% of Nordea Investment Management's portfolio in Q2 2026, its #172 holding.
  • Nordea Investment Management first reported a position in Royalty Pharma in Q4 2020 and has held it in 23 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.